skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Treatment of addiction and addiction-related behavior

Patent ·
OSTI ID:1175351
; ;

The present invention relates to the use of a composition that increases central nervous system GABA levels in a mammal, for the treatment of addiction to drugs of abuse and modification of behavior associated with addiction to drugs of abuse in said mammal.

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-98CH10886
Assignee:
Brookhaven Science Associates LLC (Upton, NY)
Patent Number(s):
6,890,951
Application Number:
09/933,157
OSTI ID:
1175351
Country of Publication:
United States
Language:
English

References (34)

Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure journal June 1997
Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward journal May 1995
Striatal binding of the PET ligand11C-raclopride is altered by drugs that modify synaptic dopamine levels journal April 1993
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. journal December 1993
Pharmacologic characterization of nicotine-induced conditioned place preference journal February 1985
Vigabatrin: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Epilepsy and Disorders of Motor Control journal January 1991
Nicotine Dependence, Midbrain Dopamine Systems and Psychiatric Disorders journal March 1995
Self-administration in rats allowed unlimited access to nicotine journal October 1997
Infusion of Nicotine in the Ventral Tegmental Area or the Nucleus Accumbens of the Rat Differentially Affects Accumbal Dopamine Release journal December 1994
Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice journal June 1998
Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens journal September 1989
Apparent absence of nicotine-induced conditioned place preference in rats journal May 1987
Control of behavior by intravenous nicotine injections in human subjects journal December 1983
Place Conditioning: A Simple and Effective Method for Assessing the Motivational Properties of Drugs book January 1987
Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine-Treated Rats journal April 1997
Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area journal January 1994
Imaging endogenous dopamine competition with [11C]raclopride in the human brain journal April 1994
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs journal July 1996
?-VINYL GABA (4-amino-hex-5-enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA-T: EFFECTS ON BRAIN GABA METABOLISM IN MICE journal November 1977
On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. journal July 1988
Treatment of Cocaine Abuse: Pharmacotherapy
  • Kleber, Herbert D.
  • Ciba Foundation Symposium 166 ‐ Cocaine: Scientific and Social Dimensions: Cocaine: Scientific and Social Dimensions: Ciba Foundation Symposium 166 https://doi.org/10.1002/9780470514245.ch11
book September 2007
Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis journal June 1984
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. journal July 1988
Basic aspects of GABA-transmission in alcoholism, with particular reference to GABA-transaminase journal February 1997
Amphetamine and vigabatrin down regulate aromatic l-amino acid decarboxylase mRNA levels journal January 1996
Cigarette smokers self-administer intravenous nicotine journal November 1983
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography journal October 1992
Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects journal September 1990
Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds journal October 1997
Pharmacological treatment of tobacco dependence journal May 1988
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats journal December 1986
Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen journal December 1990
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation journal October 1997
Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats journal October 1996

Similar Records

Related Subjects

60 APPLIED LIFE SCIENCES